Apollo Capital Urges Shareholders to Vote Gold Proxy Card for New Board, Disregard MediPharm's Green Proxy Ahead of Upcoming Shareholders Meeting

Reuters
05-21
Apollo Capital Urges Shareholders to Vote Gold Proxy Card for New Board, Disregard MediPharm's Green Proxy Ahead of Upcoming Shareholders Meeting

Apollo Technology Capital Corporation, a significant shareholder of MediPharm Labs Corp., has issued voting recommendations ahead of the company's 2025 Annual and Special Meeting of Shareholders scheduled for June 16. Apollo Capital, owning approximately 3.0% of MediPharm's common stock, urges shareholders to disregard MediPharm's green proxy card and instead vote for the gold proxy card in support of Apollo Capital's six director nominees. These nominees-John Fowler, Alan D. Lewis, David Lontini, Demetrios Mallios, Regan McGee, and Scott Walters-are presented as highly qualified candidates capable of addressing issues such as strategic failures and excessive executive compensation at MediPharm. Apollo Capital has launched a campaign website, CureMediPharm.com, to outline their five-pillar plan aimed at restoring value and accountability to the company.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediPharm Labs Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: NY92385) on May 20, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10